Accès ouvert
2026
article
OpenAlex
Jie Huang, Gang Chen, Zhehai Wang, Wenjian Jin et autres
INTRODUCTION: Deulorlatinib (TGRX-326), a potent third-generation anaplastic lymphoma kinase (ALK) inhibitor, has reported promising activity and a favorable safety profile in ALK-positive NSCLC in a phase 1 trial. Here, we report the primary results of the pivotal phase 2 trial (NCT05955391) evaluating …
cn, hk, us
(code pays fourni par la source)
Accès ouvert
2026
preprint
OpenAlex
Zihao Fan, Xin Lu, Jie Xiao, Dong Li et autres
In image restoration, single-step discriminative mappings often lack fine details via expectation learning, whereas generative paradigms suffer from inefficient multi-step sampling and noise-residual coupling. To address this dilemma, we propose IR-Flow, a novel image restoration method based on Rectified Flow that serves …
Accès ouvert
2025
article
OpenAlex
Qiong Wu, Xue Liu, Ying Xu, Hui Wu et autres
. NEXN overexpression downregulated the expression of mesenchymal markers and partially upregulated E-cadherin expression. Mechanistically, NEXN overexpression reduced β-catenin nuclear accumulation. Furthermore, by binding to MYOCD, NEXN co-regulated the EMT in HCC through the WNT/β-catenin signaling pathway. In conclusion, the diminished expression …
cn
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Jing Zhou, Cheng‐Yuan Xu, Yawen Wu, Xingyu Mao et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jiayi Wan, Shiyun Luo, Wanzhen Zhong, Jiaying Guo et autres
Background: The global rise in childhood obesity has heightened its recognition as a major public health concern, with obesity being an independent risk factor for metabolic abnormalities. However, the metabolomics mechanisms linking pediatric obesity to metabolic abnormalities remain unclear. Methods: This case-control …
cn
(code pays fourni par la source)
Accès ouvert
2025
preprint
OpenAlex
Weiyu Pan, Minying Deng, Chen Xu, Lijuan Luan et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Xin Xin, Yongfang Tang, Man Lu, Jie Huang et autres
To investigate the prognostic value of the apparent diffusion coefficient (ADC) calculated from diffusion-weighted imaging (DWI) to cytoreductive surgery (CRS), with or without hyperthermic intraperitoneal chemotherapy (HIPEC), for gastric cancer (GC) patients with peritoneal metastasis (PM). Between May 2016 and December 2020, …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jinxue Yin, Xin Xin, Chun Yao, Yongfang Tang et autres
BACKGROUND: Programmed death ligand 1 (PD-L1) expression status, closely related to immunotherapy outcomes, is a reliable biomarker for screening patients who may benefit from immunotherapy. Here, we developed and validated an interpretable machine learning (ML) model based on contrast-enhanced computed tomography (CECT) …
cn
(code pays fourni par la source)
2025
article
OpenAlex
Hui Mai, L Li, Xin Xin, Yongfang Tang et autres
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Shujuan Sun, Sha Yin, Jie Huang, Dong‐Dong Zhou et autres
Background: Identification of risk genes and loci associated with the recurrence and metastasis of breast cancer (BC) is of utmost importance. Genome-wide association studies (GWASs) represent valuable tools for identifying the disease risk associated with a given single-nucleotide polymorphism (SNP); they offer …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Jie Huang, Hao Sun, Lina Chen, Xiu-Hao Zhang et autres
Immunotherapy now plays a key role in supplementing and even replacing conventional agents in tumor treatment. Immune checkpoint inhibitors (ICIs), represented by atezolizumab and durvalumab, have shown encouraging therapeutic effects in the combination chemotherapy for extensive-stage small cell lung cancer (SCLC) and …
cn
(code pays fourni par la source)
Accès ouvert
2025
article
OpenAlex
Ranran Yang, Dan Yuan, Siying Zhu, Jie Huang et autres
Background: Colorectal cancer (CRC) is a predominant contributor to global cancer-associated mortality worldwide. Oxaliplatin (OXP), a foundational chemotherapeutic agent for CRC, often exhibits limited efficacy due to the emergence of drug resistance. Although endothelin-1 (EDN1) has been implicated in tumor drug resistance, …
cn
(code pays fourni par la source)